A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

Name: A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.
License: Public Domain

Dompé Farmaceutici S.p.A

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

new

new-onset type 1 diabetes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 426716
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.